Cochrane Abstracts
Interferon in relapsing‐remitting multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interferon in Relapsing‐remitting Multiple Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432444/all/Interferon_in_relapsing‐remitting_multiple_sclerosis.
Interferon in relapsing‐remitting multiple sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432444/all/Interferon_in_relapsing‐remitting_multiple_sclerosis. Accessed May 8, 2025.
Interferon in relapsing‐remitting multiple sclerosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432444/all/Interferon_in_relapsing‐remitting_multiple_sclerosis
Interferon in Relapsing‐remitting Multiple Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 May 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432444/all/Interferon_in_relapsing‐remitting_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interferon in relapsing‐remitting multiple sclerosis
ID - 432444
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432444/all/Interferon_in_relapsing‐remitting_multiple_sclerosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
